Sign in

Soo Hong

Director at Adverum BiotechnologiesAdverum Biotechnologies
Board

About Soo Hong

Soo Hong, 53, is a Class I independent director of Adverum Biotechnologies (ADVM) serving since March 2022, with her current term expiring at the 2027 Annual Meeting . She is Chief People Officer at Sunbit (since January 2022) and founder of Laurel Pass LLC; prior roles include CPO at National Veterinary Associates (2019–2021) and CHRO at Discovery Land Company (2017–2019). She holds a BA from Wellesley College and an MBA from the University of Chicago Booth School of Business, and brings deep expertise in human capital management and compensation governance .

Past Roles

OrganizationRoleTenureCommittees/Impact
National Veterinary AssociatesChief People OfficerMay 2019 – Dec 2021Led people services, talent, recruiting, workplace support
Discovery Land CompanyChief Human Resources OfficerSep 2017 – May 2019Oversaw talent acquisition, org development, total rewards, HR ops
Laurel Pass LLCFounder (human capital consulting)Since 2017Advised on organizational design, executive recruitment, engagement
Consulting (Capital One, Global Hyatt, Pfizer)ConsultantVariousOrganizational, recruitment, engagement strategies

External Roles

OrganizationRoleTenureNotes
Sunbit (fintech)Chief People OfficerSince Jan 2022Leads HR, recruiting, compensation, org development
Laurel Pass LLCFounderSince 2017Human capital consulting
CAMPDirector (prior)Not disclosedPrior board service (company not specified as public)

Board Governance

  • Committees: Compensation Committee member; not Chair (Comp Committee chaired by James Scopa; other members include Hong, Machado, Tuckson) .
  • Independence: Board determined Ms. Hong is independent under Nasdaq rules; comp committee members meet SEC/Nasdaq independence standards .
  • Attendance and engagement: In 2024 the Board met 4 times; Compensation Committee met 8 times; each director attended at least 75% of Board and committee meetings while serving .
  • Board tenure/class: Class I director; term through 2027 Annual Meeting .

Fixed Compensation

ComponentAmount (USD)Notes
Board annual cash retainer$40,000Standard non-employee director cash retainer
Compensation Committee member fee (non-chair)$7,500Annual cash for non-chair committee member
Total cash fees earned (2024)$47,500Reported fees earned by Soo Hong in 2024

Performance Compensation

Equity Element2024 Grant Date Fair Value (USD)Terms/VestingNotes
Stock options (non-employee director)$59,197Board Annual Awards vest in full at earlier of first anniversary or next annual meeting; Initial Options vest ratably over 3 years; max 10-year term
Director equity caps (3-year policy)Policy limitsAnnual compensation caps of $150k when market cap < $250M; scaled higher with market cap; additional option grant to Chair +30% of Board Annual Award
Plan governance featuresPolicyNo dividends pre-vesting; one-year minimum vesting (limited exceptions); no discounted options; clawback compliance; stockholder approval required for share increases

Note: ADVM is seeking stockholder approval to authorize a one-time option repricing (including director options) within 12 months post-Annual Meeting, subject to retention and value caps; eligible only for options struck above the prior 52-week high and conditioned on 12 months of continued service .

Other Directorships & Interlocks

CompanyRoleInterlocks/Notes
CAMPPrior directorNo current public-company directorships disclosed for Hong; Board independence review noted certain interlocks for other directors but none for Hong

Expertise & Qualifications

  • Human capital management, executive/leadership development, and compensation design/governance; relevant to Compensation Committee service .
  • Education: BA (Wellesley), MBA (Chicago Booth) .

Equity Ownership

ItemValueNotes
Total beneficial ownership12,000 sharesIncludes 12,000 shares subject to options exercisable within 60 days of 3/31/2025; <1% of outstanding
Options outstanding (12/31/2024)22,520 sharesTotal options held at year-end across all grants
Vested vs unvested (indicative)12,000 vs remainder12,000 options exercisable within 60 days of 3/31/2025; remainder unexercisable at that date
Ownership guidelinesNot disclosedNo director ownership guidelines disclosed in proxy; plan-level non-employee director compensation limits apply

Governance Assessment

  • Strengths

    • Independent director with relevant HR/compensation governance expertise; member of the Compensation Committee .
    • Attendance: met or exceeded the 75% threshold; Board/committee activity levels disclosed .
    • Director pay structure balanced: modest cash ($47.5k) and equity via options; policy imposes market-cap-based caps and clawback compliance .
  • Watch items / RED FLAGS

    • Proposed one-time repricing of underwater options (including directors) may raise investor alignment concerns despite retention rationale; director repricing value must stay within the annual cap and requires 12-month service post-repricing .
    • Broad option overhang and high burn rate historically acknowledged by the company; while necessary for retention, dilution remains a risk factor for equity holders .
  • Conflicts/related party exposure

    • No related-party transactions disclosed involving Ms. Hong since January 1, 2023; RPT section lists items for other individuals/entities but none for Hong .
  • Compensation committee governance

    • Compensation Committee uses independent consultant (Aon); independence affirmed; Hong is a member (chair is Scopa) .

Overall, Hong’s independence, committee placement, and HR/compensation background support board effectiveness on pay governance; monitor execution of the option repricing and ongoing equity plan dilution for investor alignment .